🇺🇸 Pantoprazol in United States

10,335 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 10,335

Most-reported reactions

1. General Physical Health Deterioration — 1,814 reports (17.55%)
2. Dyspnoea — 1,322 reports (12.79%)
3. Nausea — 1,120 reports (10.84%)
4. Anaemia — 961 reports (9.3%)
5. Fatigue — 922 reports (8.92%)
6. Dizziness — 911 reports (8.81%)
7. Diarrhoea — 874 reports (8.46%)
8. Vomiting — 854 reports (8.26%)
9. Fall — 800 reports (7.74%)
10. Pyrexia — 757 reports (7.32%)

Source database →

Frequently asked questions

Is Pantoprazol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pantoprazol in United States?

Northern Orthopaedic Division, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.